Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Aptose Bioscns (APTO)

Aptose Bioscns (APTO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Aptose Bioscns 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 CAN

P: 64-7479-9828

Description:

Aptose Biosciences Inc. is a clinical-stage biotechnology company. The company is advancing therapeutics to treat life-threatening cancers, such as acute myeloid leukemia, high-risk myelodysplastic syndromes and other hematologic malignancies. Its lead program APTO-253 has completed a Phase 1 study in patients with solid tumors. Aptose Biosciences Inc., formerly known as Lorus Therapeutics Inc., is headquartered in Toronto, Canada.

Key Statistics

Overview:

Market Capitalization, $K 244,698
Shares Outstanding, K 55,487
Annual Sales, $ 0 K
Annual Net Income, $ -28,870 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,840 K
60-Month Beta 1.75
% of Insider Shareholders 7.34%
% of Institutional Shareholders 25.61%
Float, K 51,414
% Float 92.66%

Growth:

1-Year Return 88.75%
3-Year Return 188.24%
5-Year Return -22.77%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 44.87%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 11/05/19
Earnings Per Share ttm -0.56
EPS Growth vs. Prev Qtr 7.69%
EPS Growth vs. Prev Year 25.00%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-12 on 10/07/14

APTO Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -2.93
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -109.51
Return-on-Assets (Before Tax) -92.61
Profit Margin % N/A
Net Margin % N/A
Debt/Equity 0.04
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 7.59
Book Value/Share 0.49
Interest Coverage N/A
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar